|
Abstract
Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention
in Women.
Nel A, van Niekerk N, Kapiga S, et al
N Engl J Med. 2016
Dec;375(22):2133-2143.
Abstract
Pharmacokinetic Modeling of a Gel-Delivered Dapivirine Microbicide
in Humans.
Halwes ME,
Steinbach-Rankins JM, Frieboes HB.
Eur J Pharm Sci.
2016 Aug 21
Abstract
FULL-TEXT
ARTICLE
Pharmacodynamic correlations using fresh and cryopreserved tissue
following use of vaginal rings containing dapivirine and/or
maraviroc in a randomized, placebo controlled trial.
Dezzutti CS,
Richardson-Harman N, Rohan LC,
et al
Medicine (Baltimore).
2016 Jul;95(28):e4174.
Paper
FULL-TEXT
ARTICLE
Safety,
Acceptability and Adherence of Dapivirine Vaginal Ring in a
Microbicide Clinical Trial Conducted in Multiple Countries in
Sub-Saharan Africa
Nel A, Bekker LG, Bukusi
E, et al
PLoS One. 2016 Mar
10;11(3):e0147743
Paper
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in
Women.
Baeten JM, Palanee-Phillips T, Brown ER,
et al
N Engl J Med.
2016 Feb 2
Abstract
A Phase 1 trial to assess the safety, acceptability,
pharmacokinetics
and pharmacodynamics of a novel dapivirine vaginal film.
Bunge KE, Dezzutti CS, Rohan
LC,et
al
J Acquir Immune Defic Syndr.
2015 Nov 11|
Abstract
Pharmacodynamic Activity of Dapivirine and Maraviroc
Single Entity and Combination Topical Gels for HIV-1 Prevention.
Dezzutti CS,
Yandura S, Wang L,
et al
Pharm Res.
2015 Jun 16.
Abstract
Pharmacodynamic Activity of Dapivirine and Maraviroc
Single Entity and Combination Topical Gels for HIV-1 Prevention.
Dezzutti CS,
Yandura S, Wang L,
et al
Pharm Res.
2015 Jun 16.
Abstract
Protection against re in macaques by rectal specific-gel
formulations of maraviroc and tenofovir.ctal
SHIV transmission
Dobard
CW, Taylor A, Sharma S,
et al
J Infect Dis. 2015 Jun 12|
Abstract
FULL TEXT ARTICLE
Characteristics
of Women Enrolled into a Randomized Clinical Trial of Dapivirine
Vaginal Ring for HIV-1 Prevention.
Palanee-Phillips T, Schwartz K,
Brown ER, et al
PLoS One.
2015 Jun 10;10(6):e0128857.
Paper
A
safety and pharmacokinetic trial assessing delivery of dapivirine
from a vaginal ring in healthy women.
Nel A, Haazen W, Nuttall J, Romano
J, et al
AIDS.
2014 Jun 19;28(10):1479-87.
Abstract
FULL TEXT ARTICLE
Increased
Dapivirine tissue accumulation through vaginal film codelivery of
dapivirine and Tenofovir.
Akil A, Devlin B,
Cost M, Rohan LC.
Mol Pharm.
2014 May 5;11(5):1533-41
Paper
Dual quantification of dapivirine and maraviroc in
cervicovaginal secretions from ophthalmic tear strips and
polyester-based swabs via liquid chromatographic-tandem mass
spectrometric (LC-MS/MS) analysis.
Parsons TL, Emory JF, Seserko LA, et al
J Pharm Biomed Anal.
2014 Sep;98:407-16.
Abstract
Pre-clinical development of a combination microbicide vaginal ring
containing dapivirine and darunavir.
Murphy DJ, Desjardins D,
Dereuddre-Bosquet N, et al
J Antimicrob Chemother.
2014 May 26.
Abstract
Pre-clinical development of a combination microbicide vaginal ring
containing dapivirine and darunavir.
Murphy DJ,
Desjardins D, Dereuddre-Bosquet N, et al
J Antimicrob Chemother.
2014 May 26.
Abstract
|
New
and Noteworthy
Main
New/Noteworthy
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader